198 related articles for article (PubMed ID: 30207790)
21. Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative 18F-FDG PET/CT in Patients With Very Early and Early Hepatocellular Carcinoma.
Hwang SH; Lee JW; Cho HJ; Kim KS; Choi GH; Yun M
Clin Nucl Med; 2017 Jan; 42(1):34-39. PubMed ID: 27775949
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of total lesion glycolysis measured by 18F-FDG PET/CT in patients with locally advanced cervical cancer.
Hong JH; Jung US; Min KJ; Lee JK; Kim S; Eo JS
Nucl Med Commun; 2016 Aug; 37(8):843-8. PubMed ID: 27058362
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of MTV and TLG of 18 F-FDG PET in patients with head and neck squamous cell carcinoma: A meta-analysis.
Jin A; Lin X; Yin X; Cui Y; Ma L
Medicine (Baltimore); 2022 Sep; 101(39):e30798. PubMed ID: 36181127
[TBL] [Abstract][Full Text] [Related]
24. [Prognostic value of pretreatment (18)F-FDG PET-CT for patients with advanced diffuse large B-cell lymphoma].
Ding CY; Guo Z; Sun J; Yang WP; Li TR
Zhonghua Zhong Liu Za Zhi; 2018 Jul; 40(7):528-533. PubMed ID: 30060362
[No Abstract] [Full Text] [Related]
25. Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative ¹⁸F-FDG PET/CT in Patients with Pancreatic Cancer.
Lee JW; Kang CM; Choi HJ; Lee WJ; Song SY; Lee JH; Lee JD
J Nucl Med; 2014 Jun; 55(6):898-904. PubMed ID: 24711649
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of volumetric parameters of (18)F-FDG PET in non-small-cell lung cancer: a meta-analysis.
Im HJ; Pak K; Cheon GJ; Kang KW; Kim SJ; Kim IJ; Chung JK; Kim EE; Lee DS
Eur J Nucl Med Mol Imaging; 2015 Feb; 42(2):241-51. PubMed ID: 25193652
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of 18F-FDG-PET/CT in patients with nasopharyngeal carcinoma: a systematic review and meta-analysis.
Lin J; Xie G; Liao G; Wang B; Yan M; Li H; Yuan Y
Oncotarget; 2017 May; 8(20):33884-33896. PubMed ID: 27980228
[TBL] [Abstract][Full Text] [Related]
28. Prognostic prediction by
Hu R; Zhang Y; Liu S; Lee P; Liu C; Liu A
Front Oncol; 2023; 13():1208531. PubMed ID: 37519817
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of posttreatment
Lima GM; Matti A; Vara G; Dondi G; Naselli N; De Crescenzo EM; Morganti AG; Perrone AM; De Iaco P; Nanni C; Fanti S
Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2139-2146. PubMed ID: 30069578
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of pretreatment 18F-FDG PET-CT for nasopharyngeal carcinoma patients.
Huang Y; Feng M; He Q; Yin J; Xu P; Jiang Q; Lang J
Medicine (Baltimore); 2017 Apr; 96(17):e6721. PubMed ID: 28445287
[TBL] [Abstract][Full Text] [Related]
31. Changes on Midchemoradiation Therapy Fluorodeoxyglucose Positron Emission Tomography for Cervical Cancer Are Associated with Prognosis.
Carpenter DJ; Jacobs CD; Wong TZ; Craciunescu O; Chino JP
Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):356-366. PubMed ID: 31254659
[TBL] [Abstract][Full Text] [Related]
32. Prognostic Value of Volume-Based Metabolic Parameters Obtained by 18F-FDG-PET/CT in Patients With Locally Advanced Squamous Cell Cervical Carcinoma.
Liang Y; Li X; Wan H; Fang Y; Zheng R; Zhang W; Liu Y; Chen C; Wu N
J Comput Assist Tomogr; 2018; 42(3):429-434. PubMed ID: 29369948
[TBL] [Abstract][Full Text] [Related]
33. Prognostic Value of Metabolic and Volumetric Parameters of FDG PET in Pediatric Osteosarcoma: A Hypothesis-generating Study.
Im HJ; Zhang Y; Wu H; Wu J; Daw NC; Navid F; Shulkin BL; Cho SY
Radiology; 2018 Apr; 287(1):303-312. PubMed ID: 29357275
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of metabolic tumor volume measured by FDG-PET/CT in patients with cervical cancer.
Chung HH; Kim JW; Han KH; Eo JS; Kang KW; Park NH; Song YS; Chung JK; Kang SB
Gynecol Oncol; 2011 Feb; 120(2):270-4. PubMed ID: 21109300
[TBL] [Abstract][Full Text] [Related]
35. Value of Intratumoral Metabolic Heterogeneity and Quantitative
Pinho DF; King B; Xi Y; Albuquerque K; Lea J; Subramaniam RM
AJR Am J Roentgenol; 2020 Apr; 214(4):908-916. PubMed ID: 32069078
[No Abstract] [Full Text] [Related]
36. Prognostic value of post-treatment ¹⁸F-fluorodeoxyglucose positron emission tomography in uterine cervical cancer patients treated with radiotherapy: a systematic review and meta-analysis.
Kim YJ; Han S; Kim YS; Nam JH
J Gynecol Oncol; 2019 Sep; 30(5):e66. PubMed ID: 31328452
[TBL] [Abstract][Full Text] [Related]
37. Role of Various Metabolic Parameters Derived From Baseline 18F-FDG PET/CT as Prognostic Markers in Non-Small Cell Lung Cancer Patients Undergoing Platinum-Based Chemotherapy.
Sharma A; Mohan A; Bhalla AS; Sharma MC; Vishnubhatla S; Das CJ; Pandey AK; Sekhar Bal C; Patel CD; Sharma P; Agarwal KK; Kumar R
Clin Nucl Med; 2018 Jan; 43(1):e8-e17. PubMed ID: 29112011
[TBL] [Abstract][Full Text] [Related]
38. Prognostic Value of Pretreatment Metabolic PET Parameters in Cervical Cancer Patients With Metabolic Complete Response After Concurrent Chemoradiotherapy.
Son SH; Jeong SY; Chong GO; Lee YH; Park SH; Lee CH; Hong CM; Jeong JH; Lee SW; Ahn BC; Lee J
Clin Nucl Med; 2018 Sep; 43(9):e296-e303. PubMed ID: 30036243
[TBL] [Abstract][Full Text] [Related]
39. Prognostic Value of Volumetric Parameters Measured by Pretreatment 18F FDG PET/CT in Patients With Cutaneous Malignant Melanoma.
Son SH; Kang SM; Jeong SY; Lee SW; Lee SJ; Lee J; Ahn BC
Clin Nucl Med; 2016 Jun; 41(6):e266-73. PubMed ID: 27055144
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of 18F-FDG PET/CT parameters for reflection of aggressiveness and prediction of prognosis in early-stage cervical cancer.
Zhang L; Sun H; Du S; Xu W; Xin J; Guo Q
Nucl Med Commun; 2018 Nov; 39(11):1045-1052. PubMed ID: 30204642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
